# AI Risk Models La Trobe University Launches Its BowelRec AI Tool By Adam Harrie | Written with AI assistance | Published 2026-08-20 | Tech Source: Trend Hunter, https://www.trendhunter.com/trends/la-trobe References: [mobihealthnews](https://www.mobihealthnews.com/news/anz/la-trobe-ai-flags-bowel-cancer-recurrence-risk)  La Trobe University researchers developed SÉMIL, an AI model that analyzes digital pathology slides to identify stage 2 bowel cancer patients at greater risk of relapse. The system evaluates tumor growth patterns at the invasive front, a prognostic feature that can be difficult for pathologists to classify consistently. SÉMIL was trained using 388 stage 3 bowel cancer cases and validated across more than 1,220 stage 2 patients. The model identified a higher-risk group with roughly twice the risk of relapse within five years, independent of established clinical risk factors. Researchers also found that combining SÉMIL’s assessment with a pathologist’s evaluation improved risk classification. For clinicians, the model could eventually support [more individualized follow-up and treatment decisions](https://www.trendhunter.com/trends/Clinical-AI-platforms) without requiring additional tissue samples or costly tests. The research reflects growing interest in [AI-assisted pathology for cancer risk stratification](https://www.trendhunter.com/trends/imaging-biomarkers). Image Credit: Shutterstock/YURIMA ## Trend Insights (Trend Hunter) - Score: 6.2/10 - Popularity: 49% | Activity: 45% | Freshness: 92% - Audience gender: 50% men, 50% women - Primary generations: Gen X - Top markets: Europe, Asia ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [AI](https://www.trendhunter.com/ai) ## Key Themes ### Why This Trend Is Growing - **AI-assisted Pathology:** Digital slide analysis is creating new avenues for more consistent cancer risk stratification by augmenting pathologist expertise with scalable machine learning insights. - **Predictive Cancer Modeling:** Risk models that identify relapse probability from existing clinical images are reshaping personalized oncology by reducing dependence on additional invasive tests. - **Hybrid Clinical Intelligence:** Combining clinician assessment with AI-generated classifications reveals opportunities for more precise decision support in complex diagnostic workflows. ### Industries Being Reshaped - **Oncology:** Cancer care is being transformed by tools that support individualized monitoring and treatment planning based on relapse risk prediction. - **Digital Pathology:** Pathology platforms are expanding beyond digitization toward prognostic analytics that extract clinically meaningful patterns from routine tissue slides. - **Medical AI:** Healthcare AI developers are finding growth potential in specialized models that improve decision confidence within high-stakes diagnostic environments. ## Related on Trend Hunter - [Healthcare Artificial Intelligence Platforms](https://www.trendhunter.com/trends/healthcare-artificial-intelligence-platform.md) - [Healthcare AI Models](https://www.trendhunter.com/trends/rural-areas.md) - [AI Supply Chain Monitors](https://www.trendhunter.com/trends/grubmarket-1.md) - [AI Clinical Reasoning](https://www.trendhunter.com/trends/AI-clinical-reasoning.md) - [Autonomous AI Research Systems](https://www.trendhunter.com/trends/autoscience-virtual-laboratory.md) - [AI Sports Analytics](https://www.trendhunter.com/trends/balr-ai.md) - [AI-Powered Clinical Integrations](https://www.trendhunter.com/trends/arbital-health.md) - [Clinical Triage AI Tools](https://www.trendhunter.com/trends/paediatric-emergency-ai-app.md) - [Predictive Clinical AI](https://www.trendhunter.com/trends/AITRICS.md)